AMAG Pharmaceuticals, Inc.
Lee F. Allen, MD, PhD,
Chief Medical Officer
Alka Batycky, PhD,
Vice President, Program and Alliance Management
William K. Heiden,
President, Chief Executive Officer and member of AMAG’s Board of Directors
Scott Holmes,
Chief Accounting Officer, Vice President and Controller
Greg Madison,
Executive Vice President and Chief Commercial Officer
Amy Sullivan,
Vice President, Investor Relations and Corporate Communications
Frank E. Thomas,
Chief Operating Officer
Scott B. Townsend,
Senior Vice President, General Counsel and Secretary
Christopher G. White,
Chief Business Officer
Michael Narachi,
Chairman of the Board, AMAG;
President and CEO, Orexigen Therapeutics, Inc.
Joseph V. Bonventre, MD, PhD,
Director of the Renal Division, BWH
Rajiv De Silva,
President, Valeant Pharmaceuticals International, Inc.
William K. Heiden,
President and Chief Executive Officer of AMAG
Robert J. Perez,
Executive Vice President, Chief Operating Officer, Cubist Pharmaceuticals, Inc.
Dr. Lesley Russell,
Former SVP, Head of R&D for Global Branded Products, Teva Pharmaceuticals Inc.
Gino Santini,
Retired Eli Lilly and Company Executive;
Most recently SVP, Corporate Strategy and Business Development
Davey S. Scoon,
Non-Executive Chairman, Board of Directors Tufts Health Plan